CHRONIC KIDNEY DISEASE AND CEREBROCARDIOVASCULAR COMPLICATIONS IN ARTERIAL HYPERTENSION: RESULTS OF PERINDOPRIL А USAGE WITH INDAPAMID

Aim. To evaluate the development of cardio- and cerebrovascular complications in arterial hypertension depending on presence or absence of kidney injury, to evaluate organoprotective activity of perindopril with indapamide (the medications Noliprel A and Noliprel A Forte).

Material and methods. The three-year prospective investigation has been performed on 52 outpatients with AH. The diagnosis of CKD was set according to KDOQI 2002 guidelines. All patients received antihypertensive therapy with Noliprel 2,5 + 0,625 mg (Noliprel A) — (10) or 5 + 1,25 mg (Noliprel A Forte) — (42). Control group — 25 patients on antihypertensive treatmient without Noliprel. Primary endpoint was the development of CKD or worsening of already persisting CKD to the next stage. Secondary endpoints: cardio- and cerebrovascular accident (myocardial infarction, ischemic stroke, transitory ischemic attack). Results. In the group of therapy with combination of perindopril A with indapamide primary endpoint was reached by 12 (23%) patients, in the group without this combination in 12 (48%) patients, p=0,05. Regression of severity of CKD was marked in 5 (15,5%) patients in the main group and in no one in comparison group.

In the main group with CKD the cardiocerebral events occured in 11 (33,3%) patients, in the group without kidney injury in 1 (5,25%) patient had cardiocerebral event, p<0,05. Between the main and the comparison groups there are also significant differences by the prevalence of myocardial infarction and ischemic stroke: 12 (23%) vs. 14 (56%), p=0,009. In the group of patients not taken combination of perindopril A with indapamide, cardiovascular accidents occur almost 10 times more often than in the main group without CKD, and almost 2 times more often than in CKD group with drug combination.

Conclusion. Prospective observation has shown higher prevalence of ischemic stroke and transient ischemic attack, and cardiovascular accidents in the group of patients with chronic kidney disease comparing to the group without kidney injury. Dynamic observation of the AH patients, use of perindopril+indapamide combination allows to reach antihypertensive and organoprotective aim.

1. Bikbov BT, Tomilina NA. Renal replacement therapy for ESRD patients in Russian Federation, 1998-2009. Nephrology and Dialysis 2011; 13 9 (3): 152-264. Russian (Бикбов Б. Т., Томилина Н. А. Состояние заместительной терапии больных с хро¬нической почечной недостаточностью в Российской Федерации в 1998-2009 гг. Нефрология и диализ 2011; 13 (3): 152-264).

2. Shemetova VG, Orlova GM, Sasina MS. Chronic kidney disease in patients with arterial hypertension. Sib. Med. Z. 2007; 2: 36-8. Russian (Орлова Г. М. Хроническая болезнь почек у амбулаторных больных с артериальной гипертонией. Сибирский медицин¬ский журнал 2007; 2: 36-8).

3. Shemetova VG. Chronic kidney disease in patients with arterial hypertension: prevalence, risk factors, clinical meaning ang prognosis. Irkutsk: 2012. Russian (Шеметова В. Г. Хроническая болезнь почек у больных артериальной гипертензией: частота, факторы риска развития, клинико-прогностическое значение: автореф. дис. канд. мед. наук. Иркутск: 2012).

4. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351 (13): 1296¬305.

5. Ninomiya T, Perkovic V, Verdon C, et al. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis. 2009; 53: 417-25.

6. Bos MJ, Koudstaal PJ, Hofman A, et al. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke 2007; 38: 3127-32.

7. Garg AX, Clark WF, Haynes RB, et al. Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney Int. 2007; 61: 1486-94.